Vaxxinity, Inc. (VAXX)

OTCMKTS: VAXX · Delayed Price · USD

0.0810

+0.0255 (45.95%)

May 17, 2024, 3:59 PM EDT - Market closed

Vaxxinity Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Revenue	0	0	0.07	0.56	0
Revenue Growth (YoY)	-	-	-88.15%	-	-
Cost of Revenue	2.23	1.68	1.94	0.05	0.11
Gross Profit	-2.23	-1.68	-1.87	0.51	-0.11
Selling, General & Admin	22.39	28.35	51.83	12.22	3.01
Research & Development	33.67	47.63	71.38	20.57	10.66
Other Operating Expenses	0	0	-8.37	-5.76	-0.03
Operating Expenses	56.05	75.98	123.2	32.79	13.66
Operating Income	-58.29	-75.98	-125.08	-32.28	-13.66
Interest Income	2.09	1.26	0.01	0	0.44
Interest Expense	0.7	0.51	0.84	1.18	0.44
Other Expense / Income	0.04	-0.01	11.27	6.5	0.5
Pretax Income	-56.93	-75.22	-137.18	-39.96	-14.16
Income Tax	0	-0.01	0.84	-4.58	0.06
Net Income	-56.93	-75.21	-138.02	-35.38	-14.22
Shares Outstanding (Basic)	127	126	125	125	125
Shares Outstanding (Diluted)	127	126	125	125	125
Shares Change	0.45%	0.44%	-0.05%	-	-
EPS (Basic)	-0.45	-0.60	-1.10	-0.28	-0.11
EPS (Diluted)	-0.45	-0.60	-1.10	-0.28	-0.11
Free Cash Flow	-58.04	-57.79	-82.31	-35.39	-12.27
Free Cash Flow Per Share	-0.46	-0.46	-0.66	-0.28	-0.10
Gross Margin	-	-	-2834.85%	90.66%	-
Operating Margin	-	-	-189507.58%	-5795.69%	-
Profit Margin	-	-	-209113.64%	-6351.35%	-
Free Cash Flow Margin	-	-	-124709.09%	-6353.14%	-
EBITDA	-56.05	-73.04	-123.96	-37.33	-13.58
EBITDA Margin	-	-	-187824.24%	-6701.26%	-
Depreciation & Amortization	2.23	1.68	1.1	0.72	0.11
EBIT	-58.29	-74.72	-125.07	-38.04	-13.69
EBIT Margin	-	-	-189493.94%	-6829.98%	-

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.